mrna Zc3h12a IL-6
|
|
|
- しょうこ あいしま
- 7 years ago
- Views:
Transcription
1
2 mrna Zc3h12a IL-6
3 IgG4 The 4th East Asian Group of Rheumatology (EAGOR2011) S3PE CaMK
4 EBM
5 PubMed
6
7 NHK TBS European Thyroid Journal Nature, Lancet
8
9
10 msv ICRP msv msv msv
11
12
13 WHO COE
14 sirna M M
15 M
16
17
18 VS VS
19 VS Helen P Batty GP A
20 Change H GP GP
21 URL
22
23
24
25 μsv/h GS km km
26 μsv/h km km km
27 MG Yahr IV JR
28 μsv/h μsv/hμsv/h NBC
29
30 MRI tpa
31 JAEA J ER
32 km PTSD
33 The Lancet Cedars-Sinai Medical Center IC
34
35 NHK TV km km
36 KTN
37
38
39 km
40
41 HbA1c (NGSP) %% mmhg mg/dl mg/dl mg/dl N N HbA1c % N
42 N N N
43 SD GH GH
44
45
46
47
48
49
50
51 ABI CGMS CGMS CSII
52 PET Journal of Clinical Endocrinology and Metabolism NOD
53
54 Harvard Medical University, Beth Israel Deaconess Medical Center, Rheumatology Division, George C. Tsokos Lab SLE B6.lpr mice, MRL/lpr mice etc. T George Lab Journal Club Consult Round/Grand Round Lab Meeting Journal Club Figure PI Figure CellNatureScience Consult Round/Grand Round Lab Meeting ESL play date
55 ml g JAL High impact
56 George
57 mrna RNA 㞍 mirna J Cell Biol In Focus (Ruth Williams. J Cell Biol :3) Zc3h12a IL-6 Nature Zc3h12a IL-6 IL-12 RNA regulon Figure
58 M.D. Boston Harvard Medical School, Beth Israel Deaconess Medical Center ABCC
59 TSH TSH
60 Mount Sinai Medical Center Terry F. Davies IgG4 IgG4 IgG4 MRI IgG4 PSL The 4th East Asian Group of Rheumatology (EAGOR2011) Musculoskeletal ultrasonography assists the diagnostic performance of 2010 rheumatoid arthritis criteria for rheumatoid arthritis Musculoskeletal ultrasonography assists the diagnostic performance of 2010 rheumatoid arthritis criteria 㞍
61 RS3PE RS3PE RS3PE RS3PE VEGF Ann Rheumatic Dis RS3PE RS3PE Remitting Seronegative Symmetrical Synovitis with Pitting EdemaRS3PE pitting edema NSAIDs McCarty PMR MMP-3 RS3PE MMP-3 suggestion High serum matrix metalloproteinase 3 is characteristic of patients with paraneoplastic remitting seronegative symmetrical synovitis with pitting edema syndrome. Modern Rheumatology EULAR
62 悪 性 腫 瘍 を 合 併 した RS3PE CaMK Boston, Beth Israel Deaconess Medical Center (BIDMC) Rheumatology division
63 SLE SLE H H follow 禱
64 禱
65
66 P CO2 PCR
67 M
68 Endocrinology
69 ips ips INDUCED PLURIPOTENTSTEM CELL i ipod ips
70 TEL TEL
研究成果報告書(基金分)
RA RF ACPA RA RA RA RA RA IC IC RA RA IC RA IC RA IC RA RA RA IC 1 RA OA RA RA OA WinROOF RT-PCR ELISA RA RA RA OA 1 2 Thrombospondin-1 TSP-1 Platelet factor 4 PF-4RA RA RA RA 2 2 TSP-1 TSP-1 SS SLE RF
1
1 2 3 1 1 2 3 4 5 6 2 3 4 5 6 7 8 14 4 5 6 7 8 () 9 10 3,948 3,725 2,946 11 201 12 13 4NBC 14 1. 2. 3. 4. 5.. 7... 10. 11. 12. 13. 14. 15. 16. 1. 1. 2. 3. 4. 5. 6. 7. 8. 15 1. 2. 3. 4. 1. 2. 3. 4. 5. 6.
中高齢者の健康・いきいきライフスタイルづくり調査
1 -- -- 10 11 12 1998-2000 Exercise: A Guide from the National Institute on Aging 1 61-80 26 T PHA Streptoccocal enterotoxin ASEA (IL-2; Th1 ) IL-4Th2 IgE T T - Bcl-2 Fas T PHA SEA IL2 T PHA SEA IL2
30 2012 62-2 -
HANKAKU-NEWS Niigata 30 2012 62-2 - km km - 3 - I-131 2012 12-4 - 2013 2-5 - 1986 7 26 7Km 2011 3 8 2011 3 11 2011 9 26 1972 ABCC 2011 10 27 13,000 2011 12 20-6 - 2012 5 2 2012 7 14 ( B) B 3Km 400mSv 2012
,938,235 3,876,091 3,805,600 3,704,298 3,673, , , , , , ,903
14 1 2.49 8% 1.41 1% 4.65 8% 2.24 1-1 14 1652 1.9 524 9.8% 1-2 5 55.2 912-1- 44.8 740 30 204 22.4 20 210 28.4 1-3 10 11 12 13 14 3,938,235 3,876,091 3,805,600 3,704,298 3,673,550 920,928 917,902 885,065
小児内分泌学会-03-プログラム.indd
10 2 8 30 9 55 SOP 2 P-044 P-045 2 P-046 :Frasier 1 1 1 1 1 1 2 2 1 1 2 P-047 GH 1 1 2 2 2 2 2 1 2 P-048 Bartter 1 1 1 1 2 1 2 P-049 SD IGF-1 GHD P-050-2SD GHD 1 2 2 2 1 2 P-051 GHD 1,2 1 1 1 1 1 2 2 3
函館市_絵で見てわかる
70 75 26 2 27 1 2 3 4 5 6 7 8 9 4 6 6 6 8 10 10 10 10 12 21 21 22 26 28 30 32 34 36 2 3 70 75 701 28 75 6575 7075 28 75 3 4 5 75 65 26 28 75 65 75 1 1 70 7075 2 2 2 1 260 90 210 18 9012 160 18 100 183
Treatment for Rheumatoid Arthritis in Elderly Patients to be Provided by Orthopedic Surgeons Satoshi ITO Division of Clinical Immunology, Advanced Bio
Treatment for Rheumatoid Arthritis in Elderly Patients to be Provided by Orthopedic Surgeons Satoshi ITO Division of Clinical Immunology, Advanced Biomedical Applications, Graduate School of Comprehensive
untitled
1 2 1 1 2 3 1 2 1 2 4 0,76 4 5 0,1 1970 1974 1993 6 7 8 9 4 1920 10 1960 1971 ( ) IC 11 1980 1990 1992 1987 0,269 1996 0,023 2001 2002 1996 1996 1 98 27 70 1 3 7 12 2003 63 2 13 3 5 1 13 5 14 2 14 2 14
労働法総論講義(2・完)
173 174 175 176 .... 177 ............ NHK NHK.. NHK.................. 178 ........ 179 180 181 182 183 .. 184 185 186 187 .............. 188 .. 189 .. 190 .. 191 192 193 .. 194 195 196 .............. 197
% 4.4% % 5.0% % 4.5% % 2.7% % 2.0% % 3.6% 5.1% 4.5% 2.6% 3.6%
11 10 12 8.9% 4.4% 2005 9.2% 5.0% 2006 6.5% 4.5% 2007 1.0% 2.7% 2008 1.9% 2.0% 2009 7.3% 3.6% 5.1% 4.5% 2.6% 3.6% 2012 2011 2010 2004 H22.3.27 2011 3 10 2010 9 10 2 128 60 191041 100 100 2011 JR km 89
1 1 (1) 1 1 1 (2) 1 (3) 3 3 4 4 2 6 (1) 6 (2) 6 6 6 7 3 7 (1) 7 7 9 10 10 11 (2) 12 12 14 16 (3) 17 17 18 (4) 18 18 18
1 1 (1) 1 1 1 (2) 1 (3) 3 3 4 4 2 6 (1) 6 (2) 6 6 6 7 3 7 (1) 7 7 9 10 10 11 (2) 12 12 14 16 (3) 17 17 18 (4) 18 18 18 ( ) 20 10 26 39 1 2 ( ) 3 338 4 5 6 22 10 7 50 60 8 600 400 600 400 9 10 454 11 45
untitled
2005 0211059 1 4 1 1 6 A) 7 2 8 3 9 4 10 5 11 2 JR 1 13 A) 16 ATS JR 2 18 3 20 2 4 22 5 24 6 25 3 1 27 A) B) C) 2 28 A) JR 28 B) 31 C) 35 3 36 41 3 JR 43 48 65 4 2005 4 25 JR JR JR JR 5 10 30 JR PR 5 CM
悪 性 腫 瘍 肝 転 移 における 血 清 5 -Nucleotide Titlephosphodiesterase isoenzyme-vの 腫 瘍 マーカ 義 Author(s) 山 本, 和 子 Journal 東 京 女 子 医 科 大 学 雑 誌, 57(1):42-54, 1987 URL http://hdl.handle.net/10470/6023 Twinkle:Tokyo Women's
02名簿.indb
The 6th East Asian Games Tianjin 2013 12 The 6th East Asian Games Tianjin 2013 13 The 6th East Asian Games Tianjin 2013 14 The 6th East Asian Games Tianjin 2013 15 The 6th East Asian Games Tianjin 2013
science
science IT PERSON TO PERSON EU IT IT WHO TV I T Harvard University Brigham and Women s Hospital, Renal Division UCSF CT MRI IT 1 40 17 3 27 Winslow 1949 Impact Factor 50 1 16 1 NIH Samuel W. Cushman
32
32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 1 153 PI PI IC 50 51 40 15 42 40m 40 16 15 42 42 60km/ 80km/ CO2 NO NO2 20km/h km/h CO2 NO 52 9 NO2 PI 212 PI PI 3 53 1 153 PI PI IC 54 55 20 2020
02 12 3 C C C [ (2004/2/28 )] 2. 01. [ (2002/6),p.18] (2004/3) 16 3 17 182
![02 12 3 C C C [ (2004/2/28 )] 2. 01. [ (2002/6),p.18] (2004/3) 16 3 17 182](/thumbs/40/20556211.jpg "02 12 3 C C C [ (2004/2/28 )] 2. 01. [ (2002/6),p.18] (2004/3) 16 3 17 182")
6-3. 1. 01. [ 2000 (2003/3),p.161] 02. 1 2 3 1 2 [ 2000 (2003/3),p.160] 03. 12 1 13 15 3 [ 2000 (2003/3),p.207] 04. C C 27 C (1) (2) 3 00 3 C 181 02 12 3 C C C [ (2004/2/28 )] 2. 01. [ (2002/6),p.18] (2004/3)
< E397C C5F8FB4985E2E706466>
2016 11 2613 00 17 30 2710 00 17 30 2016 Vol.11 Medical Governance Society program 50 50 NPO ( ) IRIS 108-0074 2-12-13-201 Tel; 03-6455-7432, Fax; 03-6455-7505 e-mail; genba-kyougikai@umin.net 11 26 13
ジャーナル4表紙
Jichi Medical University Journal of Nursing 7 3 4 55 63 75 a 83 93 97 3 9 5 9 3 5 7 97 5 9 6 ) 5) ) 36) 35 336 3 4 9 34 56 78 9 36 7 67 3 3 4 3 97 3 5 5 7 5 3 3 4 5 97 5 9 979 7 8564 887 97948 4 4 6
1996 papilloma virus 2001 Bowen AIHA PSL1mg/kg BMA PRCA parvovirus B19 PVB19 DNA PCR PV IgM 4 PVB19 PRCA MAP PVB19 DNA DNA PR
1996 papilloma virus 2001 Bowen2002 12 2003 2 2002 9 10 AIHA PSL1mg/kg BMAPRCA parvovirus B19 PVB19 DNA PCR PV IgM 4PVB19 PRCA MAPPVB19DNA DNA PRCA IVIG;20 50g/ IVIG PVB19AIHA steroid 15 20mg/day 2003
広域防災拠点検討会報告書030723表紙_0829_.PDF
15 3 i 15 3 ii iii iv ( ) ( ) ( ) ... i...iii... 1.... 1.... 1..... 1..... 2.... 3... 5.... 5..... 5..... 5.... 6..... 6..... 6.... 7..... 7..... 8... 12... 13.... 13..... 13..... 16..... 16.... 17....
幸せな未来のために
6 4 3 I 1 1 II III 3 1 16 4 1 16 1 1 16 10 1 17 6 5 46 18 635m 1 1995 1.17 05 46 1 17 1 2 4 10 2 7 1 4 1 2 5 4 JR 1 5 59 2005 2004 12 23 67 2005 1 12 12 1 2004 12 26 2 23 23 2006 1 2007 3 25 7 10 3 2
被曝二世健康影響調査
19 3 1 1. 3 2. 4 4 4 6 7 8 8 3. 10 10 10 11 12 4. 14 14 15 15 15 15 16 17 17 18 18 19 19 5. 20 6. 21 22 2000 7 5 4 6 4 77,000 5mGy 5mGy 24,673 57.3 84.5% 11,951 BMI 1 - 1Gy 0.91 1Gy 0.98-48.6 48.4 19 10
22 The 22nd Annual Meeting of the Japan Endocrine Pathology Society 2018 9 21 22 ( ) ( ) ( ) ( ) 22 30 9 21 22 2 22 8 14 4 5 65 12 29 30 9 22 2 Update 2018 2 770-8504 3-18-15 () () JR 30 440 25 4,000 JR
会報36号表紙
36 No. ( 2017 9 ) RNA 2017 RNA 19 7 19 21 7 8 JR RNA RNA 20 RNA RNA RNA RNA 10 50 13 26% 40 RNA RNA-SEQRNAiCRISPRCLIP RNA RNA - 1 - 3 29 8-2 - ips - 3 - - 4 - - 5 - RNA 29 RNA RNA 5 microrna trna? RNA
20－121
20 121 150 1 20 121 1 HbA1C 1 2 2 HbA1C 3 2 4 5 HbA1C 1 HbA1C -NH2 -CHO HbA1C 1 1 HbA1C HbA1C HbA1C HbA1C HbA1C 120 HbA1C HbA1C 1 2 2 HbA1C 120 10 10 10 3 β β 1 1 GAD ICA 2 4 HbA1C 2 1 2 5 2 20 121 150
274 Jpn. J. Clin. Immunol., 32 (4) 274~278 (2009) 2009 The Japan Society for Clinical Immunology 原 著 当科におけるリウマチ性多発筋痛症の臨床的特徴 青木葉子, 岩本雅弘, 簑田清次 Clinical
274 Jpn. J. Clin. Immunol., 32 (4) 274~278 (2009) 2009 The Japan Society for Clinical Immunology 原 著 当科におけるリウマチ性多発筋痛症の臨床的特徴 青木葉子, 岩本雅弘, 簑田清次 Clinical features in patients with polymyalgia rheumatica Yoko
北アルプス_燕岳～穂高_－2.doc
1 ( )22 2001 2226 30 1300m 27kg 2 JR 1000 22 10 3 500-400 au 300 N 2763m 4 N N 10 N 500m PM9:00 5 ( 2 ) 7 23 2001 2226 10 N N 40 10 30 6 5m N N N 12 3 49 30 20 2922m 7 K ( ) U S N ( ) 50 15 N 35 (2758m)
第80回日本温泉気候物理医学会.indd
第80回 The 80 th Annual Meeting of the Japanese Society of Balneology, Climatology and Physical Medicine 日本温泉気候物理医学会 総会 学術集会 プログラム 抄録集 温泉の恵み 自然の力 会 期 会 場 会 長 2015 年 6月20日 21日 軽井沢プリンスホテル ウェスト 倉 林 均 埼玉医科大学リハビリテーション医学教授
シンポジウム 報告書_5.PDF
... 2... 2... 2... 2... 2... 3... 3... 4... 6... 6... 6... 10... 10... 13... 13... 15... 17... 18... 21... 22 23... 23... 23... 24... 28... 30... 32 1 2 2 30 3 4 5 6 biodiversity 7 4 8 9 TV 10 NHK 11 12
1305目次.indd
高齢糖尿病患者のシックデイ時ケア 荒木厚 高齢糖尿病患者のシックデイ時の対応についてご教示ください 山内 sick day sick day 荒木 2 1 1frail HbA1c NGSP7.0±0.5% HbA1c NGSP 8.0±0.5% HbA1c 8.0±0.5% 7 8% HbA1c 荒木 57 54. 2013 321 1 荒木 荒木 荒木 荒木 荒木 SU SU 24 SU
200 30 984 1 1854 1713 1000 1008 ED ADL/QOL The European Working Group on Sarcopenia in Older People EWGSOP Asian Working Group for Sarcopenia AWGS D C Zhang, 2006 C Imamura, 2008 ATP Imamura, 2009 Imamura,
untitled
CONTENTS 01 02-03 04-05 06-07 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 48-49 50-51 52 01 02 Mishima,Michiaki 03 04 05 06 07 09 10 11
untitled
16 1109 2005 3 1109 1 16 1109 2 1 5 1 2 3 2 15 1 2 3 3 24 1 2 2 16 1109 1 colere nature 2 1 1982 P, 2 1967 P,135 136 3 16 1109 1 70 2 1 1997 P,68 2 2003 P,203 206 4 16 1109 5 16 1109 1 2 3 4 1 1982 P,17
Microsoft Word - 講演録.docx
2015.9.7 70 21 11 3 22 5 3 14 1 1 1 2 3 2 2 12 7 3 6 1 7 11 2 3 4 1 1 3 11 (1) (2) (2) 5 2 ( ) 6 15 6 6 2 0 PTSD PTSD PTSD 5 50 7 240 17 3 31 560 PTSD 560 500 500 8 40 9 2 11 1 1 750 700 PTSD 350 10 1
10 1-1 - 30 2-2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - 18-9 - - 10 - PTSD 100-11 - - 12 - - 13 - 17 // - 14 - 27 151-15 - - 16 - - 17 - - 18 - - 19 - - 20 - E - 21 - - 22 - - 23 - - 24 - - 25 - 28 4-26
レジャー産業と顧客満足の課題
1 1983 1983 2 3700 4800 5500 3300 15 3 100 1000 JR 4 14 2000 55% 72% 1878 2000 5 ( ) 22 1,040 5 946 42 15 25 30 30 4 14 39 1 24 8 6 390 33 800 34 34 3 35 () 37 40 1 50 40 46 47 2 55 4.43 4 16.98 40 55
67.5km 299.4km 2 2 2 16km 1/6 47km 2 1 1 (m) (km 2 ) 2,700 7.6 9,927 47.1 8,100 13.4 8,120 4.8 52 0.4 1,100 6.0 2,200 3.8 6,982 45.3 4,473 14.4 5,000 9.5 2 (km 2 ) (km) 1 299.4 67.5 2 284.5 38.8 3 267.0
10 4 2
1 10 4 2 92 11 3 8 20 10 2 10 20 10 28 3 B 78 111 104 1021 95 10 2 4 10 8 95 18 10 30 11 13 104 20 105 105 105 105 107 5 1 11 26 13301500 6 GH 1 GH 34 7 11 27 9301030 8 4 9 GH 1 23 10 20 60 --------------------------------------------------------------------------------------------------------------------------
Rinku General Medical Center
Rinku General Medical Center 4860 100 1620 Ann Intern Med. 1966; 64: 328 40 CHOP 63 1 83 J Clin Oncol. 1998; 16: 20065-69 Febrile Neutropenia IDSA(Infectious Diseases Society of America) 2002 Guidelines
< F836F A815B934B8D87955C E706466>
92897 92893 10,000 92894 10,600 92895 11,300 92896 11,900 92897 11,900 92898 15,200 2 92888 92873 4,200 92874 4,200 92875 7,000 92876 7,000 92877 7,000 92878 8,800 92879 8,800 92880 13,300 92881 8,800
( ) , 1 2 3 4 5 50 50 10 27 400 500 20 60 6 89 97 20 27 100 20 30 40 500 3000 4000 50 7 30 27 8 9 15 30 10 64 13 20 150 10 280 10 10 10 104 11 10 NHK 10 300 40 12 2000 2000 2000 500 500 500 300 500 300
Journal of Breast and Thyroid Sonology Journal of Breast and Thyroid Sonology Vol.2, No.1 January 2013 Overview History of JABTSJapan Association of Breast and Thyroid Sonology : Dawn of a JABTS Age; The
BMI BMI
() () 2 QOL () () QOL 11 6 14 20 13.9 20 BMI 12 70 40 11 6 14 20 13.9 20 BMI 12 70 40 57.1 100 ) 1 100 1 250 11 11 430 315 73.3 494 247 50.0 322 60 18.6 12 70 62 88.6 100 18 57.1 1 100 1 250 430 315 73.3
「学生とシニア」の対話実施報告書
in 2009.11.30 1. 2005 6 38 3 2 2. 3 3. 1 21 11 7 9301630 11 6 18302030 2 1 1 3 4 (90 )(50 )(75 ) 4. 5.(70 ) 6. 5 2 G1 (CO2 ) G2 () G3 () G4 (-) G5 () 5 2 10 1 CO2 Q&A 1 7. 3 2 3 9%, 62%, 27%, 2% 71% 23%,
1) a) b) CRP c) d) e) a,b b,c c,d d,e a,e b,d 2) CKD a) ACE ARB b) 2mg/dL ACE ARB c) 2mg/dL d) e) ACE ARB a,b b,c c,d d,e a,e b,d 3) a) 130/85mmHg b)
2010.1.13 1) 4) 2 18 1) 1 2 3 4 2) 1 2 85 3 3) 1 metabolizer 2 metabolizer 3 metabolizer 4 metabolizer 4) CYP 1 2 metabolizer 3 metabolizer 4 5 6 4 7 2 5 (PPI) 1 2 PPI 2 3 2 3 3 3 3 PPI 3 1 ph 4 5 1) 5)
第 14 回血管病理研究会 日時 : 平成 20 年 10 月 10 日 ( 土 ) 会場 : 佐賀大学医学部臨床大講堂 3208 号室会長 : 徳永藏 ( 佐賀大学医学部病因病態科学講座 ) CRP MPO-ANCA 125IU/l CT mpa
第 4 回血管病理研究会 日時 : 平成 20 年 0 月 0 日 ( 土 ) 会場 : 佐賀大学医学部臨床大講堂 3208 号室会長 : 徳永藏 ( 佐賀大学医学部病因病態科学講座 ). 67 2008 CRP MPO-ANCA 25IU/l 009 2 CT mpa GCA PSL 50 mg CRP MPO-ANCA mpa GCA 4 mpa ovarlap 2 TLR 2 2. 対象 方法
untitled
[] 2007 3 2 Hodgkin Plasma cell dysclasia Atrial myxoma with emboli histiocytosis multicentric reticulohistiocytosis Schuller-Christian Gaucher Weber-Christian 1.SLE 2. Gottron Gottron 3. sclerodactyly
肺癌第49巻第1号
1 Department of Diagnostic Pathology, Graduate School of edicine, Chiba University, Japan; 2 Department of Thoracic Surgery, Chiba Rosai Hospital, Japan; 3 Work Environment Research Group, National Institute
<91E58A778E6A95D28E5B89DB82BE82E682E82D91E6338D862D E706466>
2 4 3 5 100 23 2011 4 JR 1 18 14 9313 2 3 12 21 19 1886 1 4 1915 4 1929 6 13 1938 14 2 15 18 27 1952 31 3037 1962 41 1966 2 46 2 3 4 4 4 F 10 24 1891 1 4 1915 9 10 1921 13 520 12 6 18 24 1949 1 59 34 1959
一休デイサービスセンター
2770105472 2770105472 2776300135 2776300135 - - 072-274-7219 072-204-7319 http://www.19day.jp/ 072-274-7219 072-204-7319 http://www.19day.jp/ 2007 11 1 45 2007 11 1 45 11 12 4km 10 11 -2- 3-3 - 4 - 5 11
44 SLE PVB19 SLE IgM IgG PCR PVB19 IgM dsdna SLE PVB19 Lupus mimickers 8 PVB19 SLE Gottron cm 2.0SD 28.0 kg 1.1SD
33 1 43 50 2018 43 Lupus mimickers 1 2 1 2 1 2 3 1 2 1 2 3 11 SLE American College of Rheumatology ACR) SLE ATP B19 PVB19 IgM PVB19 Lupus mimickers ITP 2 SLE ATP PVB19 ITP PCR PVB19 IgM IgG 8 SLE PVB19
JA2008
A1 1 10 vs 3 2 1 3 2 0 3 2 10 2 0 0 2 1 0 3 A2 3 11 vs 0 4 4 0 0 0 0 0 3 6 0 1 4 x 11 A3 5 4 vs 5 6 5 1 0 0 3 0 4 6 0 0 1 0 4 5 A4 7 11 vs 2 8 8 2 0 0 0 0 2 7 2 7 0 2 x 11 A5 9 5 vs 3 10 9 4 0 1 0 0 5
-2- -3- 1955 1980 14 1998 1956 1995 2001 3 1964 1995 1999 2001 2-4- -5- -6- -7- NASA 2006 Eclipse Bulletin -8- -9- -10- -11- -12- 6 7 2 120mm 3 NHK 8cm 780mm ED Fast BOX 1 8 3 8 BOX 500ml4 2 5 25 2 S2pro
_PDF.indd
1 加 齢 研 ニュース 58 24 12 1 1. National Institute of Health 3 30 NIH DC 1 20? 58 1 6 8 10 11 13 14 15 12 : 25 6 29 5 : : 2 BMI 25? 1 2 2 70? 1 2 2001 9 11??? 2 3?? 1 500 1? 1,000 61 50 2.! 24 8 19 2 4 108
[ ]魏／谷垣(責+).indd
![[ ]魏／谷垣(責+).indd](/thumbs/43/23159645.jpg "[ ]魏／谷垣(責+).indd")
21 2 1 1 2 3 1. ASEAN EU 21 1 1990 12 EAE East Asia Economic Group 2001 11 1 ASEAN 3 5 2 6 ASEAN 22 ASEAN ASEAN AESAN ASEAN 3 ASEAN ASEAN 4 5 23 2005 10 3 ASEAN 3 ASEAN 10 6 ASEAN 6 ASEAN 2 6 2 1992 7
untitled
Ref. No: KiG14B23-Kokushi22-R01 22 1/23 Ans Ans 1 75 64 74 8 75 75 Ans 9 75.1 2010 Ans Ans 1000 Ans 85cm 90cm 25 130mmHg 85mmHg 100mg/dl HbA1c 5.6 HDL 150mg/dl HDL-C 40mg/dl 1 3 Ans 1 (): 2 (): 3 (): 4
調査報告書
8 15 1 2 3 4 1 2 VTR 3 4 19 19 19 1 2 3 4 5 6-1 - 23 1 2 VTR VTR MA MA 3 2 34 1 BPO - 2 - 2 3 4 5TBS 6 41 1 2 3 4 5 63 1 520 2 3 53 17 4 17 61 17 6 12 69 17 8 7 78 17 10 16 2005 SP 86 17 12 11-3 - 95 18
PowerPoint プレゼンテーション
0 1 2 3 4 5 6 1964 1978 7 0.0015+0.013 8 1 π 2 2 2 1 2 2 ( r 1 + r3 ) + π ( r2 + r3 ) 2 = +1,2100 9 10 11 1.9m 3 0.64m 3 12 13 14 15 16 17 () 0.095% 0.019% 1.29% (0.348%) 0.024% 0.0048% 0.32% (0.0864%)
10K1A NASA () SPACE ATLAS Freedom H2A NASA 1
10O1A 10 10 1 10K1A NASA () SPACE ATLAS 40 1957 1969 10 1986 1990 Freedom 20 000 H2A NASA 1 10K1A 100 10 21 40 1996 ( 200 () 2 10S1A 10 8 57 250 1 10S1A 20 200mmm 2 10S1B 18 18 1 10S1B 40 10 20 2 10S1C
Journal Club 2017/05/30 Tomohiro Matsumoto PGY-2
Journal Club 2017/05/30 Tomohiro Matsumoto PGY-2 本 の論 March 21, 2017 2 Introduc)on 3 : (CIN) 3 25% 44µmol/L(0.5mg/dL) CIN 4 European Society of Urogenital Radiology. ESUR guidelines on contrast media,
慈大呼吸器_25-1_02T_CS5.indd
ISSN 0919-6870. Jikei Journal of Chest Diseases Jikei University Chest Diseases Research Association 82 1 1 1 1 1 1 1 1 2 1 2 74 2010 2 2011 8 12 2012 1 17 1 20 1 28 CT 5 / 50 2011 8 2 / 1200 mg/2x 40
化をみる 多くの患者は急速な ADL の変化により 家人が心配し付き添って来院することが多い しかし 他覚所見に乏しく筋委縮 筋力低下もない為 単なる肩こりとされ埋もれている患者も多い 我々の所を受診する患者の多くは発症より 3 カ月くらい経っているのが現状である 急速な両肩の ROM 制限のある患
意外と多いリウマチ性多発筋痛症 福田孝昭久留米大学医療センターリウマチ膠原病センター (2013 年第 14 回博多リウマチセミナー ) はじめにリウマチ性多発筋痛症 (Polymyalgia rheumatica:pmr) は高齢者に好発し 体幹 四肢近位部のこわばりと疼痛を特徴とする原因不明の炎症性疾患である 微熱 倦怠感 体重減少やうつ状態など非特異的症状を呈するものの 理学的には特異な所見が無く
untitled
1-92009 X 22 RA 2009ACR/EULAR MTX 3 TNF 3 IL-6 1 MTX RA Key words rheumatoid arthritisra 2009RA criteria 2009 biologicstnf anti-tnf drugsremission I rheumatoid arthritisra X 1 1 2 II 629-0392 TEL0771-72-1181FAX0771-72-0326
untitled
-1- 12 3 7 8 3.5 ( ) 7 8 3 1 2 3 ( ) ( -2- 3 7 5 21 2 2-3- 2 2 18 ( 1) ( 1) ( ) 6. 9 ( 9 15 ) 7. 2 ( 9 ) ( 11 32 11 ) 11. 4 20. 10 ( 26 15 21 ) 23. 9 28. 4 ( 8 ) ( 34 ) 32. 9 ( 45 ) 32. 12 ( 10 13 ) 33.
1926
2010 10 2011 2 3 3 19 2010:369 1970 4 1 2 3 4 1 2 4 3 2010 11 1926 2011a:80 2011a:81 2008:27 2001a:82 2001a:85 2001a:82-3 2001a:95 2001b:32-3 2001b:32 2001b:33 2009:65 2005 2005:3 2005:4 2005:8 2005:8
18 () 2,000 4,300 1,200 3,900 2,000 4,000 2,200 6,000 1,600 4,100 1,400 3,900 1,800 4,200 3,400 4,100 1,600 4,000 1,600 9,400 1,800 6,400 1,200 4,100 2,000 5,400 1,800 3,900 1,800 4,000 1,800 5,400 2,500
橡9-p7.PDF
1975 1981 500 505 7,000 7 4 3 2 200 150km 150 300 100 8 300 3 2 2 2 130 2 1 600 600 130 140 9 4 1 150 200 250 140 2 1 600 3 4 160 140 160 600 600 130 10 ) 130 140 130 JR 10 30 5 2 2 ( ) 2 2 3 1 1 1 11
審査報告書（案）
19 83 7 18 628 1 19 8 3 7 18 6 28 30 MI 31 360 21700BZY00247000 5mm CEA 59 mm 2 50% 80 1. 2. 3 19 8 3 [ ] 7 [ ] [ ] [ ] [ ] 18 6 28 [ ] CEA 49mm 50 80 2 4 carotid endarterectomy CEA 1,2 CEA ECST 3 NASCET
C 1) 2) 3) 4) 5) 6) 7) 8) 9)
130603 (1-3) C 1) 2) 3) 4) 5) 6) 7) 8) 9) C 1) 2) 3) DNA 4) DNA RNA 5) 6) PCR 7) DNA C Cyclops Odlilon Redon, The Cyclops, 1914 WAGR www.wagr.org WAGR www.wagr.org Cell 126, 663-676, 2006 Wikipedia
